Ambiq Micro, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ambiq Micro, Inc. (AMBQ) on January 8, 2026, covering events occurring on January 5, 2026. The company is incorporated in Delaware and its common stock trades on the New York Stock Exchange. The filing reports a corporate governance change involving the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a new director and does not contain financial performance data.
Material Changes
Effective January 5, 2026, the Company increased the size of its Board of Directors from six to seven members. Dr. Bernard B. Banks was appointed to fill the newly created directorship. He will serve as a Class III director until the 2028 annual meeting of stockholders. Additionally, Dr. Banks was appointed to the Audit Committee.
Management Commentary and Risks
Dr. Banks brings significant leadership experience, including 29 years of active duty in the U.S. Army (retiring as a Brigadier General) and roles at Rice University and Northwestern University's Kellogg School of Management. He will be compensated according to the Company's Non-Employee Director Compensation Policy and has entered into a standard indemnification agreement. The filing states there are no family relationships between Dr. Banks and other directors or officers, and no related party transactions exist.
Key Facts for Investor Verification
- Board size increased to seven directors effective January 5, 2026.
- Dr. Bernard B. Banks appointed as a Class III director and Audit Committee member.
- Dr. Banks' compensation aligns with the existing Non-Employee Director Compensation Policy.
- No related party transactions or family relationships were disclosed regarding this appointment.
- This filing contains no financial results or forward-looking guidance.